Novo Nordisk A/S’s Gross Margin at a glance
Novo Nordisk A/S reports gross margin of 84.7% for Dec 2024. The prior period recorded 84.6% (Dec 2023). Year over year the metric moved +0.07 pts (+0.1%). The rolling three-period average stands at 84.4%. Data last refreshed Dec 7, 2025, 2:49 AM.
Latest reading
84.7% · Dec 2024
YoY movement
+0.07 pts (+0.1%)
Rolling average
84.4%
Current Gross Margin
84.7%
+0.07 pts
+0.1%
Rolling average
84.4%
Latest Value
84.7%
Dec 2024
YoY Change
+0.07 pts
Absolute
YoY Change %
+0.1%
Rate of change
3-Period Avg
84.4%
Smoothed
Narrative signal
Novo Nordisk A/S’s gross margin stands at 84.7% for Dec 2024. Year-over-year, the metric shifted by +0.07 pts, translating into a +0.1% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How gross margin shapes Novo Nordisk A/S's story
As of Dec 2024, Novo Nordisk A/S reports gross margin of 84.7%. Measure pricing power and cost of goods efficiency by reviewing historical gross margins.
Pricing versus input costs
Gross margin expands when pricing power or mix more than offset raw material and labor inflation.
Benchmark to peers
Compare margins within a sector to spot operational advantages or signs of discounting.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Novo Nordisk A/S (NVO) FAQs
Answers tailored to Novo Nordisk A/S’s gross margin profile using the latest Financial Modeling Prep data.
What is Novo Nordisk A/S's current gross margin?
As of Dec 2024, Novo Nordisk A/S reports gross margin of 84.7%. This reading reflects the latest filings and price data for NVO.
How is Novo Nordisk A/S's gross margin trending year over year?
Year-over-year, the figure shifts by +0.07 pts (+0.1%). Pair this context with revenue growth and free cash flow signals to gauge momentum for NVO.
Why does gross margin matter for Novo Nordisk A/S?
Gross margin tracks the percentage of revenue remaining after direct production and service delivery costs. For Novo Nordisk A/S, operating within Healthcare — Drug Manufacturers - General, tracking this metric helps benchmark management's execution against close competitors.
Is Novo Nordisk A/S's gross margin above its recent average?
Novo Nordisk A/S's rolling three-period average sits at 84.4%. Comparing the latest reading of 84.7% to that baseline highlights whether momentum is building or fading for NVO.
How frequently is Novo Nordisk A/S's gross margin refreshed?
Data for NVO was last refreshed on Dec 7, 2025, 2:49 AM and updates automatically every 24 hours, keeping your valuation inputs current.